Back to companies
Actinium Pharmaceuticals, Inc.
ATNMUSNYSEPharmaceuticals & HealthcareActinium Pharmaceuticals, Inc.
Revenue
$90,000
FY2025
Operating income
-$36.2mn
FY2025
Employees
—
Founded
—
Source: U.S. Securities and Exchange Commission (SEC) EDGAR Company Facts API